REFRACTORY WHO GRADE 1 GLIOMA

Clinical trials for REFRACTORY WHO GRADE 1 GLIOMA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY WHO GRADE 1 GLIOMA trials appear

Sign up with your email to follow new studies for REFRACTORY WHO GRADE 1 GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for kids with recurrent brain cancer: testing a powerful drug combo

Disease control Ongoing

This study is for children and young adults whose low-grade brain tumor has come back or stopped responding to treatment. It aims to find out if combining two drugs, selumetinib and vinblastine, works better than using selumetinib alone to control the tumor and prevent it from gr…

Matched conditions: REFRACTORY WHO GRADE 1 GLIOMA

Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

REFRACTORY WHO GRADE 1 GLIOMA

Get alerted when new REFRACTORY WHO GRADE 1 GLIOMA trials appear

New hope for kids with recurrent brain cancer: testing a powerful drug combo